Abstract

The development of mesoporous silica nanoparticle-based platforms for a controlled drug delivery was studied. Mesoporous silica nanoparticles (MSN) was synthesized and modified with 3-aminopropyltriethoxysilane (APTES) using co-condensation (MSNco) and post-grafting (MSNpost) methods. X-ray diffraction (XRD) and transmission electron microscopy (TEM) data confirmed the formation of ordered mesostructured silica nanoparticles. The performance of MSNs was then tested on an ibuprofen immobilization and release. The results revealed that unmodified MSN demonstrated the best immobilization rate and capacity of ibuprofen (98%), MSNpost exhibited higher ibuprofen adsorption (78%) as compared to MSNco (71%), suggesting the modification method is not the dominant factor for the adsorption studied. In fact, according to the FT-IR results, the silanol groups density was found to be the contributing factor that affected the adsorption. The in vitro drug release was also investigated with simulated biological fluids. In 20h, MSNco showed the fastest release of ibuprofen (100%), followed by MSN (50%) and MSNpost (38%). Both pore size and amine groups influenced the rate of the release process. From the results, MSN and MSNpost is suggested to have suitable features for slow drug release which provides constant release over a defined period to avoid repeated administration. While MSNco could be best employed as a fast release system that provides initial burst of drug release to achieve rapid and maximum relief.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.